Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Medical Legal
The Impact of Caronia Case: What Happens Next?
Last month, in a landmark ruling, the United States Court of Appeals for the Second Circuit in United States v. Caronia, vacated…
The Supreme Court and “Pay for Delay:” The Potential Impact on…
In early December of last year, the U.S. Supreme Court agreed to hear a case to decide whether agreements between brand-name…
FDLI: Insights in Enforcement, Litigation & Compliance for…
Last week, we were fortunate enough to attend the Food and Drug Law Institute’s (FDLI) Enforcement, Litigation & Compliance…
United States v. Caronia: A Victory for Free Speech vs. Off Label Promotion
The United States Court of Appeals for the Second Circuit (New York), in a 2-1 opinion, vacated the criminal conviction of a…
Friedman vs. Sebelius: Purdue Executive Exclusion Upheld, but Terms Voided…
The U.S. Court of Appeals for the District of Columbia recently held in Friedman v. Sebelius that the Department of Health and…
GlaxoSmithKline (GSK) Settlement and Corporate Integrity Agreement
The Department of Justice (DOJ) announced its largest health care fraud settlement in U.S. history: $3 Billion from…
Abbott Settlement and Corporate Integrity Agreement
Continuing the recent trend of large legal settlements with pharmaceutical companies, the Department of Justice (DOJ) this week…
Stryker Biotech: Case Dismissed Charges Dropped
Over the past few years, there has been no shortage of legal cases brought by federal and state prosecutors against drug and…
DOJ Failed Case against GSK Staff Lawyer Lauren Stevens: Lessons Learned
In November 2010, the Department of Justice (DOJ) issued a press release discussing a six-count indictment against Lauren Stevens…
CMS and OMB Announce New Fraud Measures
In 2010, the President announced three goals for cutting improper payments in federal health programs by 2012: reducing overall…